KIORA PHARMACEUTICALS, INC.: 10-Q filed 2018-11-13

Name: KIORA PHARMACEUTICALS, INC.: 10-Q filed 2018-11-13
Creator: KIORA PHARMACEUTICALS, INC.

What KIORA PHARMACEUTICALS, INC. reported in its quarterly report filed 2018-11-13 (fiscal Q3 2018): 39 published measures, 100 facts as tagged in accession 0001144204-18-059360.

This filing

Form: 10-Q (quarterly report)
Filed: 2018-11-13
Fiscal period: fiscal Q3 2018
Accession: 0001144204-18-059360 on SEC EDGAR

Values are as tagged in this filing. A later filing can restate them; each measure links to its history page, which shows the latest-filed value per period. All KIORA PHARMACEUTICALS, INC. filings.

Reported measures

Total assets

Resources recognized on the balance sheet. Book assets are not the market value of the business.

Period	Value	Unit	Days
At 2018-09-30	16,652,082	USD
At 2017-12-31	14,305,392	USD

Total liabilities

Recognized obligations at the reporting date. The definition and scope differ from interest-bearing debt.

Period	Value	Unit	Days
At 2018-09-30	5,551,998	USD
At 2017-12-31	16,232,314	USD

Stockholders equity

The reported residual interest after liabilities. It is an accounting amount, not market capitalization.

Period	Value	Unit	Days
At 2018-09-30	11,100,084	USD
At 2017-12-31	-1,926,922	USD

Cash and cash equivalents

Cash and qualifying short-term liquid investments under the filer’s accounting policy. Restricted cash and longer-term investments may be reported separately.

Period	Value	Unit	Days
At 2018-09-30	9,900,094	USD
At 2017-12-31	7,806,029	USD

Net income or loss

Reported profit or loss for the period. Check the filing for attribution, exceptional items and discontinued operations before comparing companies.

Period	Value	Unit	Days
2018-07-01 to 2018-09-30	-3,123,836	USD	92
2018-01-01 to 2018-09-30	-8,283,418	USD	273
2017-07-01 to 2017-09-30	-4,140,368	USD	92
2017-01-01 to 2017-09-30	-10,386,885	USD	273

Operating cash flow

Cash generated or used by operating activities. Working-capital timing can make this differ substantially from reported income.

Period	Value	Unit	Days
2018-01-01 to 2018-09-30	-8,840,996	USD	273
2017-01-01 to 2017-09-30	-5,015,231	USD	273

Capital expenditure payments

Cash payments to acquire property, plant and equipment. This taxonomy concept does not capture every form of investment or acquisition.

Period	Value	Unit	Days
2018-01-01 to 2018-09-30	20,000	USD	273
2017-01-01 to 2017-09-30	0	USD	273

Revenue

Revenue under this specific accounting concept. A missing value is not zero; filers can use other revenue concepts.

Period	Value	Unit	Days
2018-07-01 to 2018-09-30	314,500	USD	92
2018-01-01 to 2018-09-30	1,652,520	USD	273
2017-07-01 to 2017-09-30	74,696	USD	92
2017-01-01 to 2017-09-30	407,518	USD	273

Financing cash flow

Net cash from financing activities, including borrowing, repayments and transactions with owners. A positive amount does not establish operating profitability.

Period	Value	Unit	Days
2018-01-01 to 2018-09-30	11,194,693	USD	273
2017-01-01 to 2017-09-30	10,620,417	USD	273

Investing cash flow

Net cash from investing activities, including asset purchases, disposals and investment transactions. This differs from capital expenditure payments alone.

Period	Value	Unit	Days
2018-01-01 to 2018-09-30	-270,000	USD	273
2017-01-01 to 2017-09-30	0	USD	273

Retained earnings or deficit

Accumulated undistributed earnings or deficit at the reporting date. This balance is not cash available for distribution.

Period	Value	Unit
At 2018-09-30	-90,622,193	USD
At 2018-01-02	-82,338,775	USD
At 2017-12-31	-91,816,655	USD

Net property, plant and equipment

Carrying amount of property, plant and equipment after accumulated depreciation, depletion and amortization. It is not replacement cost or market value.

Period	Value	Unit	Days
At 2018-09-30	50,187	USD
At 2017-12-31	55,751	USD

Share-based compensation expense

Reported noncash expense for share-based payment arrangements. Noncash treatment does not mean the awards have no economic cost to shareholders.

Period	Value	Unit	Days
2018-01-01 to 2018-09-30	620,335	USD	273
2017-01-01 to 2017-09-30	700,833	USD	273

Operating income or loss

Operating revenue less operating expenses for the reporting period. It excludes items outside the reported operating result and is not free cash flow.

Period	Value	Unit	Days
2018-07-01 to 2018-09-30	-3,177,878	USD	92
2018-01-01 to 2018-09-30	-8,355,245	USD	273
2017-07-01 to 2017-09-30	-4,140,104	USD	92
2017-01-01 to 2017-09-30	-10,386,510	USD	273

Current assets

Assets classified as current under the normal operating cycle or one-year boundary. Not all current assets can be converted immediately into cash.

Period	Value	Unit	Days
At 2018-09-30	10,581,314	USD
At 2017-12-31	8,459,305	USD

Interest expense

Borrowing costs recognized as interest expense. This is distinct from cash interest paid and may not include every capitalized borrowing cost.

Period	Value	Unit	Days
2018-07-01 to 2018-09-30	304	USD	92
2018-01-01 to 2018-09-30	912	USD	273
2017-07-01 to 2017-09-30	304	USD	92
2017-01-01 to 2017-09-30	912	USD	273

Current liabilities

Obligations classified as current under the operating-cycle or one-year boundary. The balance includes more than short-term borrowing.

Period	Value	Unit	Days
At 2018-09-30	4,157,935	USD
At 2017-12-31	14,833,536	USD

Current accounts payable

Current amounts owed to suppliers for goods and services received. This is one component of current liabilities, not all accrued obligations.

Period	Value	Unit	Days
At 2018-09-30	324,183	USD
At 2017-12-31	706,089	USD

Goodwill carrying amount

Recognized goodwill remaining after accumulated impairment. It arises from business combinations and does not measure the current value of the company’s brand.

Period	Value	Unit	Days
At 2018-09-30	1,525,896	USD
At 2017-12-31	1,525,896	USD

Operating expenses

Recurring operating costs under this accounting concept, generally excluding production costs included in cost of sales. Check filing presentation before combining expense subtotals.

Period	Value	Unit	Days
2018-07-01 to 2018-09-30	3,492,378	USD	92
2018-01-01 to 2018-09-30	10,007,765	USD	273
2017-07-01 to 2017-09-30	4,214,800	USD	92
2017-01-01 to 2017-09-30	10,794,028	USD	273

Research and development expense

Research and development costs recognized as expense. Capitalization policies and acquired projects can make this differ from total cash invested in development.

Period	Value	Unit	Days
2018-07-01 to 2018-09-30	2,259,701	USD	92
2018-01-01 to 2018-09-30	6,618,509	USD	273
2017-07-01 to 2017-09-30	3,175,978	USD	92
2017-01-01 to 2017-09-30	7,253,171	USD	273

Common shares outstanding

Common shares outstanding at the reporting date. This point-in-time count differs from the weighted-average shares used for earnings per share and can exclude other share classes.

Period	Value	Unit	Days
At 2018-09-30	43,444,130	shares
At 2017-12-31	17,257,255	shares

Cash including restricted cash

Cash, cash equivalents and restricted cash as reported in the cash flow reconciliation. Restricted amounts are not freely available, so this is not the same as unrestricted cash.

Period	Value	Unit
At 2018-09-30	9,945,094	USD
At 2017-12-31	7,851,029	USD
At 2017-09-30	9,244,570	USD
At 2016-12-31	3,635,224	USD

Additional paid-in capital

Capital contributed above par value under this concept. It records historical contributions, not the current value of the equity or cash on hand.

Period	Value	Unit	Days
At 2018-09-30	101,150,700	USD
At 2017-12-31	89,589,681	USD

Accumulated other comprehensive income or loss

Cumulative other comprehensive items after tax, such as translation and unrealized hedging or securities effects. These amounts have not passed through net income.

Period	Value	Unit	Days
At 2018-09-30	137,095	USD
At 2017-12-31	127,473	USD

Total equity including noncontrolling interests

Equity including the portion attributable to noncontrolling interests. It is larger than or equal to parent stockholders equity and is not market capitalization.

Period	Value	Unit	Days
At 2018-09-30	11,100,084	USD
At 2017-12-31	7,550,958	USD

Gross property, plant and equipment

Cost of property, plant and equipment before accumulated depreciation. Historical cost does not indicate current value or replacement cost.

Period	Value	Unit	Days
At 2018-09-30	99,575	USD
At 2017-12-31	79,575	USD

Accumulated depreciation on property, plant and equipment

Cumulative depreciation, depletion and amortization recorded against property, plant and equipment. It measures cost allocation to date, not physical wear or market value.

Period	Value	Unit	Days
At 2018-09-30	49,388	USD
At 2017-12-31	23,824	USD

Net intangible assets excluding goodwill

Intangible assets other than goodwill after amortization and impairment. Internally developed intangibles are usually not recognized, so this understates what a company relies on.

Period	Value	Unit	Days
At 2018-09-30	4,162,314	USD
At 2017-12-31	3,912,314	USD

Other noncurrent assets

Noncurrent assets the filer does not present separately. The composition differs by filer and is described only in the filing.

Period	Value	Unit	Days
At 2018-09-30	287,371	USD
At 2017-12-31	307,126	USD

Accrued current liabilities

Current obligations accrued for goods and services received but not yet invoiced or paid. This is one component of current liabilities, not all short-term obligations.

Period	Value	Unit	Days
At 2018-09-30	1,147,752	USD
At 2017-12-31	1,813,847	USD

Prepaid expenses and other current assets

Prepayments and other current assets grouped under this concept. The balance is not cash and its composition differs by filer.

Period	Value	Unit	Days
At 2018-09-30	663,773	USD
At 2017-12-31	629,591	USD

Pre-tax income or loss from continuing operations

Income or loss from continuing operations before income taxes and noncontrolling interests. It excludes discontinued operations and is not net income.

Period	Value	Unit	Days
2018-07-01 to 2018-09-30	-3,177,878	USD	92
2018-01-01 to 2018-09-30	-8,355,245	USD	273

General and administrative expense

General and administrative costs reported under this concept, separate from selling expense. Filers group overhead differently, so compare presentation before comparing companies.

Period	Value	Unit	Days
2018-07-01 to 2018-09-30	1,232,677	USD	92
2018-01-01 to 2018-09-30	3,389,256	USD	273
2017-07-01 to 2017-09-30	1,038,822	USD	92
2017-01-01 to 2017-09-30	3,540,857	USD	273

Depreciation expense

Depreciation recognized for the period under this concept. It is a noncash allocation of asset cost and may exclude amortization and depletion reported elsewhere.

Period	Value	Unit	Days
2018-07-01 to 2018-09-30	9,633	USD	92
2018-01-01 to 2018-09-30	25,564	USD	273
2017-07-01 to 2017-09-30	4,536	USD	92
2017-01-01 to 2017-09-30	13,608	USD	273

Depreciation, depletion and amortization

Combined depreciation, depletion and amortization for the period. A noncash allocation of asset cost, not a measure of maintenance spending.

Period	Value	Unit	Days
2018-01-01 to 2018-09-30	25,564	USD	273
2017-01-01 to 2017-09-30	13,608	USD	273

Nonoperating income or expense

Total nonoperating income or expense, which can include interest, investment results and other items. A positive value is not operating profit.

Period	Value	Unit	Days
2018-07-01 to 2018-09-30	54,042	USD	92
2018-01-01 to 2018-09-30	71,827	USD	273
2017-07-01 to 2017-09-30	-264	USD	92
2017-01-01 to 2017-09-30	-375	USD	273

Proceeds from issuing common stock

Cash received from issuing common stock during the period. It is gross of costs only where the filer reports it so, and it does not include noncash issuances.

Period	Value	Unit	Days
2018-01-01 to 2018-09-30	10,108,762	USD	273
2017-01-01 to 2017-09-30	10,589,183	USD	273
2017-01-01 to 2017-03-31	1,800,000	USD	90

Change in accounts payable

The cash flow adjustment for the change in payables during the period. A positive value under this concept means payables grew and added to operating cash flow.

Period	Value	Unit	Days
2018-01-01 to 2018-09-30	-381,907	USD	273
2017-01-01 to 2017-09-30	-753,513	USD	273

Inspect the source

Entity: KIORA PHARMACEUTICALS, INC. / CIK 0001372514
Captured: 2026-09-20T07:57:09.611Z
SEC response SHA-256: 3c8ad9197d1b760a7f418642919ba51ce1343d392d1a4d1fce0d72996117d019

Current SEC company facts · Download the original response snapshot (gzip) · Download the selected JSON

Every published concept a filing tagged, with the periods it covered, as reported in that filing at capture time. Forms 10-K, 10-K/A, 10-Q, 10-Q/A, 20-F, 20-F/A, 40-F, 40-F/A. A filing page needs at least 8 published concepts. Later filings can restate these values; the company history pages show the latest-filed value per period.

Public company accounting reference, not market prices, returns, an investment recommendation, or ALPHAC performance. Validate a separately constructed return series with the validation API; accounting values are not returns.

Use this in research

A financial period ends before its results become public. Use the filing date as a minimum availability boundary, inspect amendments, and retain the original filing vintage when testing historical signals. This latest-filed selection can contain information unavailable at the time.

These pages do not supply prices, total-return histories, corporate-action adjustments or a tradable universe. Build those inputs separately before evaluating a strategy. A profitable backtest can still reflect selection bias or costs that were left out.

Research methodology · Execution and cost assumptions · Check backtest overfitting

Build with the open-source tools

Use these accounting records as inspectable inputs. When you have constructed a return series, the validation tools can help test its statistical evidence and preserve the result with its limitations.

Read the published dataset with Python

import json
from urllib.request import urlopen

with urlopen("https://canlicapital.com/company-data/0001372514.json") as response:
    record = json.load(response)
print(record["fetched_at"])
print(record["policy"])
for concept in record["concepts"]:
    print(concept["tag"], next(iter(concept["observations"])))